Page last updated: 2024-08-23

lonidamine and Carcinoma, Ductal, Breast

lonidamine has been researched along with Carcinoma, Ductal, Breast in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amadori, D; Gasperi-Campani, A; Roncuzzi, L; Zoli, W	1

Other Studies

1 other study(ies) available for lonidamine and Carcinoma, Ductal, Breast

Article	Year
Saporin 6 and lonidamine in primary cell cultures from human breast carcinomas: a synergistic effect. Anti-cancer drug design, 1997, Volume: 12, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Immunotoxins; Indazoles; Middle Aged; N-Glycosyl Hydrolases; Phenotype; Plant Proteins; Receptors, Estrogen; Receptors, Progesterone; Ribosome Inactivating Proteins, Type 1; Saporins; Tumor Cells, Cultured	1997

Article

Year

Saporin 6 and lonidamine in primary cell cultures from human breast carcinomas: a synergistic effect.

Anti-cancer drug design, 1997, Volume: 12, Issue:2

Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Cycle; Drug Screening Assays, Antitumor; Drug Synergism; Female; Humans; Immunotoxins; Indazoles; Middle Aged; N-Glycosyl Hydrolases; Phenotype; Plant Proteins; Receptors, Estrogen; Receptors, Progesterone; Ribosome Inactivating Proteins, Type 1; Saporins; Tumor Cells, Cultured

1997